Latest filing published 23 Mar 2007 for Halozyme Therapeutics, INC., €42k.
Insider track record
No signal scores available.
Richard C. Yocum: trading record in brief
Richard C. Yocum is a declared insider of Halozyme Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 21 March 2007 to 22 March 2007, the count stands at 10 filings.
The open-market record consists of 8 sales worth €190k, with no purchase. Besides market trades, the filings include 2 option exercises.
The record was last updated on 23 March 2007 with an option exercise (€42k) in Halozyme Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard C. Yocum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 29,858 shares@ US$1.87Common StockSEC:0001181431-07-021088:0
- 65,975 shares@ US$1.87Common StockSEC:0001181431-07-021088:1
- 300 shares@ US$8.46Common StockSEC:0001181431-07-021088:2
- 8,300 shares@ US$8.45Common StockSEC:0001181431-07-021088:3
- 158 shares@ US$8.47Common StockSEC:0001181431-07-021088:4
- 100 shares@ US$8.49Common StockSEC:0001181431-07-021088:5
- 17,900 shares@ US$8.50Common StockSEC:0001181431-07-021088:6
- 2,600 shares@ US$8.52Common StockSEC:0001181431-07-021088:7
- 300 shares@ US$8.56Common StockSEC:0001181431-07-021088:8
- 200 shares@ US$8.63Common StockSEC:0001181431-07-021088:9
10 of 10 declarations
